Ordeniza, Juncris P.

HRN: 20-79-98  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/12/2022
04/19/2022
IV
30MG
Q12
PCAP-C UTI
Waiting Final Action 
04/10/2022
CEFUROXIME 750MG (VIAL)
04/10/2022
04/17/2022
IV
145MG
Q8H
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: